Main

Celther Polska is well positioned to become a Polish leader in the development of next generation drug discovery solutions, particularly stem cell based therapies.

Celther is the first Polish company dedicated to bringing stem cells therapy into the biopharmacy and begins the challenge of designing stem cell therapy for general treatment. Currently, Celther Poland is focused on development of cell based therapies for diabetes, Parkinson's disease and Multiple Sclerosis.